Pediatric cancer chemotherapy:  an updated review.  I. Cis-Diammine--dichloroplatinum II (cisplatin), VM-26 (teniposide), VP-16 (etoposide), mitomycin C.
D002648:Child; D002945:Cisplatin / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008937:Mitomycins / Q000008:administration & dosage* / Q000009:adverse effects; D009369:Neoplasms / Q000188:drug therapy*; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013713:Teniposide / Q000008:administration & dosage* / Q000009:adverse effects
D008937:Mitomycins; D005047:Etoposide; D013713:Teniposide; D011034:Podophyllotoxin; D002945:Cisplatin